Size:96 Wells
In Stock
Request Bulk
Order Quote
Contact Us:
  • Toll Free: (888)880-0001
  • Phone: (858)552-6979
  • Email:
Shipping Info:
  • $40: Antibody & Protein in US
  • $50: 1-2 Kits in US
  • Contact us for international orders.

SIRT1 ELISA Kit (Mouse) (OKEH03539)

Catalog#: OKEH03539
Domestic: within 1-2 weeks delivery | International: 1-2 weeks
More Information
Predicted Species Reactivity Mouse
Kit Detection Method Colorimetric, OD450 nm
Kit Duration ~ 3 Hours
Kit Linearity Mean recovery when spiking into serum: 101%
Kit Principle Aviva Systems Biology SIRT1 ELISA Kit (Mouse) (OKEH03539) is based on standard sandwich enzyme-linked immuno-sorbent assay technology. An antibody specific for Sirt1 has been pre-coated onto a 96-well plate (12 x 8 Well Strips) and blocked. Standards or test samples are added to the wells and removed. A biotinylated detector antibody specific for Sirt1 is added, incubated and followed by washing. Avidin-Peroxidase Conjugate is then added, incubated and unbound conjugate is washed away. An enzymatic reaction is produced through the addition of TMB substrate which is catalyzed by HRP generating a blue color product that changes yellow after adding acidic stop solution. The density of yellow coloration read by absorbance at 450 nm is quantitatively proportional to the amount of sample Sirt1 captured in well.
Kit Range 31.2 - 2000pg/mL
Kit Recovery Mean recovery when spiking into sample matrices at concentrations within the dynamic range: 99%
Kit Reproducibility Mean Intra-assay CV%: < 6.3% (n = 20)
Mean Inter-assay CV%: < 7.6% (n = 20)
Kit Component
Sirt1 Microplate96 Wells (12 x 8 Well strips)
Sirt1 Lyophilized Standard2
Sample Diluent1 x 20 mL
100X Biotinylated Sirt1O Detector Antibody1 x 120 uL
100X Avidin-HRP Conjugate1 x 120 uL
Detector Antibody Diluent1 x 10 mL
Conjugate Diluent1 x 12 mL
25X Wash Buffer1 x 30 mL
TMB Substrate1 x 10 mL
Stop Solution1 x 10 mL
Reconstitution and Storage Store as indicated in product manual.
Sample Type Serum, Plasma, Tissue Homogenates, Cell Culture Supernates, Other Biological Fluids
Sensitivity 15.68 pg/mL
Datasheets/Manuals Click here to download product manual. As variation between lots may occur, always reference the lot-specific manual received with each kit.
Specificity Natural and recombinant Mouse NAD-dependent deacetylase sirtuin-1
Assay Info Assay Methodology: Quantitative Sandwich ELISA
Gene Symbol SIRT1
Official Gene Full Name sirtuin 1
Alias Symbols AA673258, MGC150273, mSIR2a, NAD-dependent deacetylase sirtuin-1, Sir2, Sir2a, Sir2alpha, SIR2alpha, Sir2l1, SIR2L1, SIR2-like protein 1
NCBI Gene Id 93759
Protein Name NAD-dependent protein deacetylase sirtuin-1
Description of Target NAD-dependent protein deacetylase that links transcriptional regulation directly to intracellular energetics and participates in the coordination of several separated cellular functions such as cell cycle, response to DNA damage, metobolism, apoptosis and autophagy. Can modulate chromatin function through deacetylation of histones and can promote alterations in the methylation of histones and DNA, leading to transcriptional repression. Deacetylates a broad range of transcription factors and coregulators, thereby regulating target gene expression positively and negatively. Serves as a sensor of the cytosolic ratio of NAD+/NADH which is altered by glucose deprivation and metabolic changes associated with caloric restriction. Is essential in skeletal muscle cell differentiation and in response to low nutrients mediates the inhibitory effect on skeletal myoblast differentiation which also involves 5'-AMP-activated protein kinase (AMPK) and nicotinamide phosphoribosyltransferase (NAMPT). Component of the eNoSC (energy-dependent nucleolar silencing) complex, a complex that mediates silencing of rDNA in response to intracellular energy status and acts by recruiting histone-modifying enzymes. The eNoSC complex is able to sense the energy status of cell: upon glucose starvation, elevation of NAD+/NADP+ ratio activates SIRT1, leading to histone H3 deacetylation followed by dimethylation of H3 at 'Lys-9' (H3K9me2) by SUV39H1 and the formation of silent chromatin in the rDNA locus. Deacetylates 'Lys-266' of SUV39H1, leading to its activation. Inhibits skeletal muscle differentiation by deacetylating PCAF and MYOD1. Deacetylates H2A and 'Lys-26' of HIST1H1E. Deacetylates 'Lys-16' of histone H4 (in vitro). Involved in NR0B2/SHP corepression function through chromatin remodeling: Recruited to LRH1 target gene promoters by NR0B2/SHP thereby stimulating histone H3 and H4 deacetylation leading to transcriptional repression. Proposed to contribute to genomic integrity via positive regulation of telomere length; however, reports on localization to pericentromeric heterochromatin are conflicting. Proposed to play a role in constitutive heterochromatin (CH) formation and/or maintenance through regulation of the available pool of nuclear SUV39H1. Upon oxidative/metabolic stress decreases SUV39H1 degradation by inhibiting SUV39H1 polyubiquitination by MDM2. This increase in SUV39H1 levels enhances SUV39H1 turnover in CH, which in turn seems to accelerate renewal of the heterochromatin which correlates with greater genomic integrity during stress response. Deacetylates 'Lys-382' of p53/TP53 and impairs its ability to induce transcription-dependent proapoptotic program and modulate cell senescence. Deacetylates TAF1B and thereby represses rDNA transcription by the RNA polymerase I. Deacetylates MYC, promotes the association of MYC with MAX and decreases MYC stability leading to compromised transformational capability. Deacetylates FOXO3 in response to oxidative stress thereby increasing its ability to induce cell cycle arrest and resistance to oxidative stress but inhibiting FOXO3-mediated induction of apoptosis transcriptional activity; also leading to FOXO3 ubiquitination and protesomal degradation. Appears to have a similar effect on MLLT7/FOXO4 in regulation of transcriptional activity and apoptosis. Deacetylates DNMT1; thereby impairs DNMT1 methyltransferase-independent transcription repressor activity, modulates DNMT1 cell cycle regulatory function and DNMT1-mediated gene silencing. Deacetylates RELA/NF-kappa-B p65 thereby inhibiting its transactivating potential and augments apoptosis in response to TNF-alpha. Deacetylates HIF1A, KAT5/TIP60, RB1 and HIC1. Deacetylates FOXO1, which increases its DNA binding ability and enhances its transcriptional activity leading to increased gluconeogenesis in liver. Inhibits E2F1 transcriptional activity and apoptotic function, possibly by deacetylation. Involved in HES1- and HEY2-mediated transcriptional repression. In cooperation with MYCN seems to be involved in transcriptional repression of DUSP6/MAPK3 leading to MYCN stabilization by phosphorylation at 'Ser-62'. Deacetylates MEF2D. Required for antagonist-mediated transcription suppression of AR-dependent genes which may be linked to local deacetylation of histone H3. Represses HNF1A-mediated transcription. Required for the repression of ESRRG by CREBZF. Modulates AP-1 transcription factor activity. Deacetylates NR1H3 AND NR1H2 and deacetylation of NR1H3 at 'Lys-434' positively regulates transcription of NR1H3:RXR target genes, promotes NR1H3 proteosomal degradation and results in cholesterol efflux; a promoter clearing mechanism after reach round of transcription is proposed. Involved in lipid metabolism. Implicated in regulation of adipogenesis and fat mobilization in white adipocytes by repression of PPARG which probably involves association with NCOR1 and SMRT/NCOR2. Deacetylates ACSS2 leading to its activation, and HMGCS1. Involved in liver and muscle metabolism. Through deacteylation and activation of PPARGC1A is required to activate fatty acid oxidation in skeletel muscle under low-glucose conditions and is involved in glucose homeostasis. Involved in regulation of PPARA and fatty acid beta-oxidation in liver. Involved in positive regulation of insulin secretion in pancreatic beta cells in response to glucose; the function seems to imply transcriptional repression of UCP2. Proposed to deacetylate IRS2 thereby facilitating its insulin-induced tyrosine phosphorylation. Deacetylates SREBF1 isoform SREBP-1C thereby decreasing its stability and transactivation in lipogenic gene expression. Involved in DNA damage response by repressing genes which are involved in DNA repair, such as XPC and TP73, deacetylating XRCC6/Ku70, and faciliting recruitment of additional factors to sites of damaged DNA, such as SIRT1-deacetylated NBN can recruit ATM to initiate DNA repair and SIRT1-deacetylated XPA interacts with RPA2. Also involved in DNA repair of DNA double-strand breaks by homologous recombination and specifically single-strand annealing independently of XRCC6/Ku70 and NBN. Transcriptional suppression of XPC probably involves an E2F4:RBL2 suppressor complex and protein kinase B (AKT) signaling. Transcriptional suppression of TP73 probably involves E2F4 and PCAF. Deacetylates WRN thereby regulating its helicase and exonuclease activities and regulates WRN nuclear translocation in response to DNA damage. Deacetylates APEX1 at 'Lys-6' and 'Lys-7' and stimulates cellular AP endonuclease activity by promoting the association of APEX1 to XRCC1. Increases p53/TP53-mediated transcription-independent apoptosis by blocking nuclear translocation of cytoplasmic p53/TP53 and probably redirecting it to mitochondria. Deacetylates XRCC6/Ku70 at 'Lys-537' and 'Lys-540' causing it to sequester BAX away from mitochondria thereby inhibiting stress-induced apoptosis. Is involved in autophagy, presumably by deacetylating ATG5, ATG7 and MAP1LC3B/ATG8. Deacetylates AKT1 which leads to enhanced binding of AKT1 and PDK1 to PIP3 and promotes their activation. Proposed to play role in regulation of STK11/LBK1-dependent AMPK signaling pathways implicated in cellular senescence which seems to involve the regulation of the acetylation status of STK11/LBK1. Can deacetylate STK11/LBK1 and thereby increase its activity, cytoplasmic localization and association with STRAD; however, the relevance of such activity in normal cells is unclear. In endothelial cells is shown to inhibit STK11/LBK1 activity and to promote its degradation. Deacetylates SMAD7 at 'Lys-64' and 'Lys-70' thereby promoting its degradation. Deacetylates CIITA and augments its MHC class II transactivation and contributes to its stability. Deacetylates MECOM/EVI1. Deacetylates PML at 'Lys-487' and this deacetylation promotes PML control of PER2 nuclear localization. During the neurogenic transition, repress selective NOTCH1-target genes through histone deacetylation in a BCL6-dependent manner and leading to neuronal differentiation. Regulates the circadian expression of several core clock genes, including ARNTL/BMAL1, RORC, PER2 and CRY1 and plays a critical role in maintaining a controlled rhythmicity in histone acetylation, thereby contributing to circadian chromatin remodeling. Deacetylates ARNTL/BMAL1 and histones at the circadian gene promoters in order to facilitate repression by inhibitory components of the circadian oscillator. Deacetylates PER2, facilitating its ubiquitination and degradation by the proteosome. Protects cardiomyocytes against palmitate-induced apoptosis (PubMed:11250901, PubMed:11672522, PubMed:12651913, PubMed:12887892, PubMed:12960381, PubMed:15175761, PubMed:15220471, PubMed:15632193, PubMed:15744310, PubMed:15788402, PubMed:16098828, PubMed:16366736, PubMed:16790548, PubMed:16892051, PubMed:17098745, PubMed:17347648, PubMed:17620057, PubMed:17901049, PubMed:17936707, PubMed:18004385, PubMed:18296641, PubMed:18371449, PubMed:18477450, PubMed:18662546, PubMed:18662547, PubMed:18687677, PubMed:19299583, PubMed:19356714, PubMed:20817729, PubMed:21176092, PubMed:21187328, PubMed:21189328, PubMed:21622680, PubMed:23160044). Deacetylates XBP1 isoform 2; deacetylation decreases protein stability of XBP1 isoform 2 and inhibits its transcriptional activity. Involved in the CCAR2-mediated regulation of PCK1 and NR1D1. Deacetylates CTNB1 at 'Lys-49' (By similarity). In POMC (pro-opiomelanocortin) neurons, required for leptin-induced activation of PI3K signaling (PubMed:20620997).By similarity <p>Manually curated information which has been propagated from a related experimentally characterized protein.</p> <p><a href="/manual/evidences#ECO:0000250">More…</a></p> Manual assertion inferred from sequence similarity toiUniProtKB:Q96EB6 (SIR1_HUMAN)35 Publications <p>Manually curated information for which there is published experimental evidence.</p> <p><a href="/manual/evidences#ECO:0000269">More…</a></p> Manual assertion based on experiment iniRef.3"Negative control of p53 by Sir2alpha promotes cell survival under stress." Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Cell 107:137-148(2001) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH TP53, ENZYME REGULATION, MUTAGENESIS OF HIS-355.Ref.4"Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription." Muth V., Nadaud S., Grummt I., Voit R. EMBO J. 20:1353-1362(2001) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF TAF1B.Ref.5"The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells." McBurney M.W., Yang X., Jardine K., Bieman M., Th'ng J., Lemieux M. Mol. Cancer Res. 1:402-409(2003) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION.Ref.7"Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state." Fulco M., Schiltz R.L., Iezzi S., King M.T., Zhao P., Kashiwaya Y., Hoffman E., Veech R.L., Sartorelli V. Mol. Cell 12:51-62(2003) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH MYOD1 AND PCAF, MUTAGENESIS OF HIS-355.Ref.8"Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice." Cheng H.-L., Mostoslavsky R., Saito S., Manis J.P., Gu Y., Patel P., Bronson R., Appella E., Alt F.W., Chua K.F. Proc. Natl. Acad. Sci. U.S.A. 100:10794-10799(2003) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION.Ref.9"Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma." Picard F., Kurtev M., Chung N., Topark-Ngarm A., Senawong T., Machado De Oliveira R., Leid M., McBurney M.W., Guarente L. Nature 429:771-776(2004) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN ADIPODIGENESIS, FUNCTION IN FAT MOBILIZATION, INTERACTION WITH PPARG AND NCOR1.Ref.10"Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases." Hallows W.C., Lee S., Denu J.M. Proc. Natl. Acad. Sci. U.S.A. 103:10230-10235(2006) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF ACSS2, FUNCTION IN REGULATION OF ACCS2.Ref.11"SIRT1 deacetylates and positively regulates the nuclear receptor LXR." Li X., Zhang S., Blander G., Tse J.G., Krieger M., Guarente L. Mol. Cell 28:91-106(2007) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF NR1H3 AND NR1H2, FUNCTION IN REGULATION OF NR1H3.Ref.12"SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization." Han M.K., Song E.K., Guo Y., Ou X., Mantel C., Broxmeyer H.E. Cell Stem Cell 2:241-251(2008) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN APOPTOSIS.Ref.13"Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity." Daitoku H., Hatta M., Matsuzaki H., Aratani S., Ohshima T., Miyagishi M., Nakajima T., Fukamizu A. Proc. Natl. Acad. Sci. U.S.A. 101:10042-10047(2004) [PubMed] [Europe PMC] [Abstract]Cited for: INTERACTION WITH FOXO1, FUNCTION IN DEACETYLATION OF FOXO1, MUTAGENESIS OF HIS-355.Ref.15"Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice." Moynihan K.A., Grimm A.A., Plueger M.M., Bernal-Mizrachi E., Ford E., Cras-Meneur C., Permutt M.A., Imai S. Cell Metab. 2:105-117(2005) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN REGULATION OF INSULIN SECRETION.Ref.16"SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1." Bouras T., Fu M., Sauve A.A., Wang F., Quong A.A., Perkins N.D., Hay R.T., Gu W., Pestell R.G. J. Biol. Chem. 280:10264-10276(2005) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION.Ref.17"Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes." Frescas D., Valenti L., Accili D. J. Biol. Chem. 280:20589-20595(2005) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN REGULATION OF FOXO1.Ref.18"Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1." Rodgers J.T., Lerin C., Haas W., Gygi S.P., Spiegelman B.M., Puigserver P. Nature 434:113-118(2005) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF PPARGC1A, FUNCTION IN REGULATION OF GLUCOSE HOMEOSTASIS, INDUCTION.Ref.20"Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage." Wang C., Chen L., Hou X., Li Z., Kabra N., Ma Y., Nemoto S., Finkel T., Gu W., Cress W.D., Chen J. Nat. Cell Biol. 8:1025-1031(2006) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH E2F1, MUTAGENESIS OF HIS-355.Ref.21"Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells." Bordone L., Motta M.C., Picard F., Robinson A., Jhala U.S., Apfeld J., McDonagh T., Lemieux M., McBurney M., Szilvasi A., Easlon E.J., Lin S.J., Guarente L. PLoS Biol. 4:E31-E31(2006) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN REGULATION OF INSULIN SECRETION.Ref.22"Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1." Wong S., Weber J.D. Biochem. J. 407:451-460(2007) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF RB1.Ref.23"Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha." Gerhart-Hines Z., Rodgers J.T., Bare O., Lerin C., Kim S.H., Mostoslavsky R., Alt F.W., Wu Z., Puigserver P. EMBO J. 26:1913-1923(2007) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF PPARGC1A, FUNCTION IN REGULATION OF MUSCLE METABOLISM.Ref.24"SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation." Kume S., Haneda M., Kanasaki K., Sugimoto T., Araki S., Isshiki K., Isono M., Uzu T., Guarente L., Kashiwagi A., Koya D. J. Biol. Chem. 282:151-158(2007) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF SMAD7.Ref.26"The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation." Zhang J. J. Biol. Chem. 282:34356-34364(2007) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WIT IRS1 AND IRS2.Ref.27"SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation." Vaquero A., Scher M., Erdjument-Bromage H., Tempst P., Serrano L., Reinberg D. Nature 450:440-444(2007) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE.Ref.28"SIRT1 regulates circadian clock gene expression through PER2 deacetylation." Asher G., Gatfield D., Stratmann M., Reinke H., Dibner C., Kreppel F., Mostoslavsky R., Alt F.W., Schibler U. Cell 134:317-328(2008) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, SUBCELLULAR LOCATION, INDUCTION, INTERACTION WITH CLOCK; ARNTL AND PER2.Ref.29"The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control." Nakahata Y., Kaluzova M., Grimaldi B., Sahar S., Hirayama J., Chen D., Guarente L.P., Sassone-Corsi P. Cell 134:329-340(2008) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INDUCTION, INTERACTION WITH CLOCK AND ARNTL.Ref.30"Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt." Fulco M., Cen Y., Zhao P., Hoffman E.P., McBurney M.W., Sauve A.A., Sartorelli V. Dev. Cell 14:661-673(2008) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION.Ref.32"SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation." Lan F., Cacicedo J.M., Ruderman N., Ido Y. J. Biol. Chem. 283:27628-27635(2008) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF STK11, FUNCTION IN POSSIBLE REGULATION OF STK11.Ref.34"A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy." Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., Tsokos M., Alt F.W., Finkel T. Proc. Natl. Acad. Sci. U.S.A. 105:3374-3379(2008) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN AUTOPHAGY.Ref.35"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation." Purushotham A., Schug T.T., Xu Q., Surapureddi S., Guo X., Li X. Cell Metab. 9:327-338(2009) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN REGULATION OF PPARA, INTERACTION WITH PPARA.Ref.38"Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis." Ramsey K.M., Yoshino J., Brace C.S., Abrassart D., Kobayashi Y., Marcheva B., Hong H.K., Chong J.L., Buhr E.D., Lee C., Takahashi J.S., Imai S., Bass J. Science 324:651-654(2009) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH ARNTL.Ref.40"SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity." Ramadori G., Fujikawa T., Fukuda M., Anderson J., Morgan D.A., Mostoslavsky R., Stuart R.C., Perello M., Vianna C.R., Nillni E.A., Rahmouni K., Coppari R. Cell Metab. 12:78-87(2010) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, DISRUPTION PHENOTYPE.Ref.41"SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism." Ponugoti B., Kim D.H., Xiao Z., Smith Z., Miao J., Zang M., Wu S.Y., Chiang C.M., Veenstra T.D., Kemper J.K. J. Biol. Chem. 285:33959-33970(2010) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN DEACETYLATION OF SREBF1, FUNCTION IN REGULATION OF SREBF1.Ref.42"SIRT1 contributes to telomere maintenance and augments global homologous recombination." Palacios J.A., Herranz D., De Bonis M.L., Velasco S., Serrano M., Blasco M.A. J. Cell Biol. 191:1299-1313(2010) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN TELOMERE MAINTENANCE.Ref.47"A nutrient-sensitive interaction between Sirt1 and HNF-1alpha regulates Crp expression." Grimm A.A., Brace C.S., Wang T., Stormo G.D., Imai S. Aging Cell 10:305-317(2011) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH HNF1A.Ref.49"Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation." Powell M.J., Casimiro M.C., Cordon-Cardo C., He X., Yeow W.S., Wang C., McCue P.A., McBurney M.W., Pestell R.G. Cancer Res. 71:964-975(2011) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN AUTOPHAGY, DISRUPTION PHENOTYPE.Ref.50"MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1." Zhu H., Yang Y., Wang Y., Li J., Schiller P.W., Peng T. Cardiovasc. Res. 92:75-84(2011) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN PALMITATE-INDUCED APOPTOSIS, INDUCTION, DOWN-REGULATION BY PALMITATE.Ref.52"BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets." Tiberi L., van den Ameele J., Dimidschstein J., Piccirilli J., Gall D., Herpoel A., Bilheu A., Bonnefont J., Iacovino M., Kyba M., Bouschet T., Vanderhaeghen P. Nat. Neurosci. 15:1627-1635(2012) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION IN NEUROGENESIS, INTERACTION WITH BCL6. Isoform 2: Isoform 2 is shown to deacetylate 'Lys-382' of p53/TP53, however with lower activity than isoform 1. In combination, the two isoforms exert an additive effect. Isoform 2 regulates p53/TP53 expression and cellular stress response and is in turn repressed by p53/TP53 presenting a SIRT1 isoform-dependent auto-regulatory loop.By similarity <p>Manually curated information which has been propagated from a related experimentally characterized protein.</p> <p><a href="/manual/evidences#ECO:0000250">More…</a></p> Manual assertion inferred from sequence similarity toiUniProtKB:Q96EB6 (SIR1_HUMAN) SirtT1 75 kDa fragment: catalytically inactive 75SirT1 may be involved in regulation of apoptosis. May be involved in protecting chondrocytes from apoptotic death by associating with cytochrome C and interfering with apoptosome assembly.By similarity <p>Manually curated information which has been propagated from a related experimentally characterized protein.</p> <p><a href="/manual/evidences#ECO:0000250">More…</a></p> Manual assertion inferred from sequence similarity toiUniProtKB:Q96EB6 (SIR1_HUMAN)
Swissprot Id Q923E4
Protein Accession # NP_062786.1
Nucleotide Accession # NM_019812.3
Protein Size (# AA) 737
Molecular Weight 80 kDa
Tissue Tool Find tissues and cell lines supported by DNA array analysis to express Sirt1.
RNA Seq Find tissues and cell lines supported by RNA-seq analysis to express Sirt1.
Write Your Own Review
You're reviewing:SIRT1 ELISA Kit (Mouse) (OKEH03539)
Your Rating